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Interleukin-10 Down-Regulates MHC Class II
ab Peptide Complexes at the Plasma Membrane
of Monocytes by Affecting Arrival and Recycling
addition, IL-10 decreases the plasma membrane ex-
pression of major histocompatibility complex (MHC)
class II glycoproteins (de Waal Malefyt et al., 1991a,
1991b). Down-regulation of MHC class II on monocytes
correlates with a decrease in proliferation and cytokine
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cells. We inferred that the down-regulation of MHC classNetherlands Cancer Institute
II antigen complexes by IL-10 prevented, rather thanPlesmanlaan, 121
inhibited, the activation of T cells. In the present investi-1066CX Amsterdam
gation, we have examined the effects of IL-10 on plasmaThe Netherlands
membrane expression of MHC class II glycoproteins
from freshly isolated human monocytes and have stud-
ied the mechanism of its action.Summary
The biosynthesis and transport of MHC class II mole-
cules is a tightly regulated process that involves theInterleukin-10 (IL-10) inhibits antigen-specific T cell
intersection of secretory and endocytic pathways (re-responses when human monocytes are used as anti-
viewed by Cresswell, 1994) to load newly synthesizedgen-presenting cells. This is correlated with a down-
MHC class II molecules with peptides generated for the
regulation of MHC class II molecules on the surface
most part from antigens degraded in the endosomal/
of the monocyte. Here we show that IL-10 does not lysosomal organellar system. During biosynthesis, the
affect MHC class II transcription, polypeptide synthe- immature MHC class II complex comprises ab hetero-
sis, subunit assembly, or antigenic peptide loading. dimers that associate in the endoplasmic reticulum with
Instead, newly synthesized mature MHC class II mole- a nonpolymorphic third glycoprotein, designated the in-
cules are localized to the MHC class II loading com- variant chain (Ii). Ii facilitates the proper folding of the
partment but are prevented from reaching the plasma ab subunits and targets the MHC class II complex to
membrane. In addition, treatment of monocytes with the endosomal/lysosomal system. There it is degraded
IL-10 leads to an accumulation of internalized MHC by resident proteases, leaving a roughly 20±amino acid
class II complexes in intracellular vesicles. These re- residue intermediate that is eventually removed from
sults indicate that IL-10 affects antigen presentation the ab heterodimer in a reaction catalyzed by another
by regulating MHC exocytosis and recycling. nonpolymorphic MHC class II heterodimeric molecule,
human leukocyte antigen-DM (HLA-DM) (Denzin and
Introduction Cresswell, 1995; Sherman et al., 1995; Sloan et al.,
1995). HLA-DM is located in lysosome-like MHC class
Interleukin-10 (IL-10), an 18 kDa homodimeric cytokine II±containing compartments (MIICs) (Sanderson et al.,
1994) where the dissociation of Ii enables peptides to(Vieira et al., 1991), is secreted by activated T cells (Yssel
occupy a groove in the MHC class II molecule. A laget al., 1992), B cells (Matthes et al., 1993), and mono-
period of approximately 1±3 hr transpires before thecytes (de Waal Malefytet al., 1991a)and binds to specific
mature MHC class II complex arrives at the plasmareceptors that are expressed on all haematopoietic cells
membrane (Neefjes and Ploegh, 1992), where it serves(Liu et al., 1994). Although it is a cofactor for the growth
as a ligand for clonotypic T cell receptors. At the celland differentiation of B cells (DeFrance et al., 1992;
surface, MHC class II molecules can recycle (Reid andRousset et al., 1992), mast cells (Thompson-Snipes et
Watts, 1990; Pinet et al., 1995; Cella, 1997) and exchangeal., 1991), and murine T cells (MacNeil et al., 1990), IL-
their antigenic peptides (Pinet et al., 1995; Cella, 1997;10 also has strong immunosuppressive and antiinflam-
Zhong, 1997).matory activities (reviewed by Moore et al., 1993).
Recently, immature dendritic cells derived from hu-In humans, IL-10 has been shown to inhibit the prolif-
man monocytes following culturewith granulocyte-mac-eration of and IL-2 production by activated human T
rophage colony-stimulating factor (GM-CSF) and IL-4cells (de Waal Malefyt et al., 1991b) and is able to induce
were shown to increase their cell surface expression ofa state of antigen-specific nonresponsiveness (Groux
MHC class II through a process involving decreasedet al., 1996). The effects of IL-10 on human monocytes
internalization coupled with increased synthesis, wheninclude inhibition of lipopolysaccharide-induced proin-
stimulated with lipopolysaccharide or tumor necrosis
flammatory cytokine secretion (de Waal Malefyt et al.,
factor-a (TNFa) (Cella, 1997). In a related study, mouse
1991a; 1993) as well as down-regulation of constitutive
bone marow±derived dendritic cells cultured in the pres-
or cytokine-induced expression of cell adhesion and ence of GM-CSF were shown to increase their cell sur-
costimulatory molecules such as CD54 (ICAM-1), CD80, face expression of MHC class II through a process in-
and CD86 (Kubin et al., 1994; Willems et al., 1994). In volving decreased internalization, coupled with more
efficient exocytosis (Pierre, 1997). Therefore, the relative
level of cell surface MHC class II expression can be³To whom correspondence should be addressed (rene@dnax.org).
regulated posttranslationally, both by exocytosis and§Present address: Novartis Research Institute, Brunner Strasse, 59,
A-1235 Wien, Austria. by recycling.
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Here we show that IL-10 acts on these same post-
translational processes and interferes with the exo-
cytosis of newly synthesized, as well as the recycling
of internalized MHC class II molecules in human mono-
cytes. Of particular interest is that the effect imposed
by IL-10 on the newly synthesized pool of MHC class II
occurs relatively late in thebiosynthetic pathway, subse-
quent to the association of MHC class II with antigenic
peptides. Vesicular transport of MHC class II molecules
can thus be negatively regulated by the IL-10 signaling
pathway.
Results
IL-10 Affects Cell Surface MHC
Class II Expression
The effect of IL-10 on constitutive or IFNg-induced cell
surface MHC class II expression by human monocytes
was initially examined by immunofluorescence and flow
cytometry. IFNg was used as a potent monocyte activa-
tor that strongly up-regulates MHC class II expression
(Basham and Merigan, 1983). Human monocytes used
in these experiments were isolated by negative selection
from buffy coats of healthy donors and were 85%±95%
positive for CD14. Cells were stained after a 15 hr culture
at 378C either in the absence of or in the presence of
IFNg and IL-10, or after an equivalent period of time at
48C. Since monocytes are able to produce low levels of
IL-10 in culture (de Waal Malefyt et al., 1991a), control
cultures weresupplemented with a neutralizing antibody
to IL-10 (monoclonal antibody [MAb] 12G8). Three anti-
MHC class II antibodies were used (Figure 1). Two MAbs
were directed against conformational epitopes of HLA-
DR (L243 and TuÈ 36), and one antibody was directed
Figure 1. Effect of IL-10 on Cell Surface MHC Class II Expressionagainst an HLA-DRb chain epitope (Q5/13). In addition,
by Human Monocytesan antibody to a conformational determinant on MHC
Human monocytes were isolated from peripheral blood and culturedclass I molecules (G46-2.6) was included as a control.
for 15 hr at 48C (t 5 0) or at 378C in the presence of a neutralizingFollowing culture with 12G8, the level of HLA-DR ex-
antibody to IL-10 (12G8, 2IL-10) or IL-10. Identical cultures werepression was increased, as assessed by the binding
set up with the addition of recombinant human IFNg. Cells were
of all three HLA-DR antibodies. In contrast, monocytes stained by indirect immunofluorescence using TuÈ 36 and Q5/13 (anti-
cultured in the presence of IL-10 showed a dramatic HLA-DR) and a horse anti-mouse IgG-PE second antibody. G46-2.6
decrease in HLA-DRexpression, to one third of the initial (anti-MHC class I) and L243 (anti-HLA-DR) antibodies were directly
conjugated to PE. Stained cells were analyzed by flow cytometry.level of HLA-DR. IFNg induced an even stronger en-
Neg, isotype-matched controls.hancement of MHC class II expression, which was also
significantly inhibited by IL-10. These results indicate
that the IL-10±mediated loss of HLA-DR staining is not
dependent on the epitope recognized by the detecting MHC class II expression on IL-10±treated cells did not
further increase. Instead, MHC class II expression de-antibody and therefore reflects a genuine down-regula-
tion of HLA-DR from the plasma membrane. Cell surface creased until 16 hr, from which time forward they re-
mained constant. By 16 hr of culture in the presence oflevels of HLA-DQ and HLA-DP followed the same pattern
of expression as HLA-DR (data not shown). In addition, IL-10, the mean fluorescence intensity of MHC class II
on the surface of the monocytes represented only 15%IL-10 is not responsible for a general down-regulation
of cell surface molecules, since the levels of MHC class of the initial level. In contrast, a sustained increase over
time in MHC class II cell surface expression was ob-I and CD14 on monocytes remain unaffected (Figure 1,
de Waal Malefyt et al., 1993) and levels of CD16, CD64, served on monocytes cultured in the presence of the
anti-IL-10 MAb, until a plateau was reached at 16 hr.and TNFa p55 receptors actually increase (te Velde et
al., 1992). Spontaneous up-regulation of MHC class II on human
monocytes cultured in vitro has been reported pre-We nextexamined the kinetics by which IL-10 affected
constitutive and IFNg-induced MHC class II expression viously (Smith and Ault, 1981). The increased expres-
sion of MHC class II upon in vitro culture of monocytes(Figure 2). The cell surface levels of MHC class II in-
creased on control and IL-10±treated monocytes up to could not be attributed to stimulation through the Fc
receptor (Barcy et al., 1995) by the anti-IL-10 MAb, sinceapproximately 4 hr (Figure 2A). Of note, the levels of
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affected by IL-10 in cultures either with or without IFNg
(Figure 3A). As expected, the expression levels of HLA-
DRA, Ii, HLA-DMA, and HLA-DMB mRNA were up-regu-
lated in the presence of IFNg.
Subsequently, the synthesis of MHC class II a, b,
and Ii polypeptides was addressed. MHC class II was
immunoprecipitated from metabolically labeled mono-
cytes using anti-MHC class II antibodies (DA6.147 and
L243) or an anti-Ii antibody (rabbit anti-Ii). As a control
for equal loading, an MHC class I (W6/32) antibody was
used. Cells had been preincubated in the presence of
the anti-IL-10 MAb or IL-10 for 8 hr, a period sufficient
to observe a substantial decrease in cell surface MHC
class II. Immediately following a 20 min pulse in the
absence (Figure 3B) or presence (Figure 3C) of IFNg,
the MHC class II abIi complex was present in both the
anti-IL-10 MAb±treated and the IL-10±treated mono-
cytes. When adjusted for loading, very similar levels of
immunoprecipitated complexes were present in both
cultures (Figure 3D). These results indicate that transla-
tion and subunit assembly of the MHC class II complex
is not affected by IL-10.
IL-10 Does Not Affect the Generation of SDS-Stable
Figure 2. Time Course of IL-10 Mediated Down-Regulation of MHC Compact Class II Complexes
Class II on Human Monocytes
Failure to bind peptide into Ii-dissociated MHC class II
Monocytes were cultured in medium alone, or with 10 mg/ml anti-IL-
complexes has been reported to prevent plasma mem-10 whole Ig, or 30 mg/ml anti-IL-10 F(ab)92, or 50 mg/ml recombinant
brane transport of newly synthesized MHC class II com-soluble IL-10 receptor, or 400 U/ml IL-10.
plexes as a result of aggregation and eventual degrada-(A) Cells were removed from culture at the indicated times and
stainedwith L243-PE (anti-HLA-DR) andanalyzed by flow cytometry. tion (Germain and Rinker, 1993). Peptide loading leads
(B) Identical cultures were set up with the addition of 400 U/ml to a conformational change of MHC class II complexes,
recombinant human IFNg. biochemically characterized by increased resistance to
denaturation by SDS (Germain and Hendrix, 1991;
Neefjes and Ploegh, 1992). Therefore, we examined theF(ab)92 fragments of the same antibody, as well as the fraction of peptide-loaded MHC class II complexes inaddition of a soluble IL-10R, did not prevent the up-
IL-10±treated monocyte cultures by their ability to retainregulation of MHC class II. Without the addition of the
subunit association in the presence of SDS. We hadanti-IL-10 MAb, F(ab)92 fragments of the anti-IL-10 MAb, previously determined by pulse chase analysis and im-or soluble IL-10 receptors, endogenously produced IL-
munoprecipitation that the Ii had dissociated from MHC10 could down-regulate MHC class II expression after
class II complexes in monocytes cultured in the absence12 hr.
or presence of IL-10 by 2 hr after synthesis (data notWhen monocytes were cultured in the presence of
shown).IFNg and either the anti-IL-10 MAb, anti-IL-10 F(ab)92,
Figure 4A illustrates that immediately after a 20 minor soluble IL-10 receptors (Figure 2B), their MHC class
pulse, MHC class II complexes in control and IL-10±II expression increased steadily to high levels up to 20
treated monocytes dissociate into the a and b subunits,hr. Similarly, MHC class II expression on monocytes
since these complexes have not entered the peptidecultured with IFNg and IL-10 also increased during the
loading compartment. However, after 2 hr of chase,first 2±4 hr. However, during the following 8±12 hr of
SDS-stable compact MHC class II complexes are pres-incubation MHC class II levels were strongly reduced.
ent. Most importantly, the fraction of SDS-resistantThese kinetics indicate that a lag period of 2±4 hr exists
dimers is very similar in monocytes cultured in the pres-between the binding of IL-10 to its receptor and inhibi-
ence of IL-10 or the anti-IL-10 MAb. Analysis of SDS-tion of constitutive or IFNg-induced MHC class II cell
stable MHC class II complexes from monocytes incu-surface expression.
bated with IFNg (Figure 4B) also reveals that the fraction
of SDS-stable dimers is comparable in control and IL-IL-10 Does Not Affect Transcription or
10±treated cells when MHC class II is expressed at highTranslation of MHC Class II Subunits
levels.To examine whether IL-10 exerted its effects on MHC
class II expression at the transcriptional level, RNA was
extracted from monocytes cultured in the absence or IL-10 Affects Accumulation of MHC Class II
at the Plasma Membranepresence of IFNg and either the anti-IL-10 MAb or IL-
10 and analyzed for the expression of HLA-DRA, Ii, HLA- To address whether newly synthesized MHC class II
complexes could accumulate at the plasma membrane,DMA, and HLA-DMB transcripts. The levels of steady-
state mRNA expression of these four genes were not we used an antibody captureassay (Krangel et al., 1979).
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Figure 3. Examination of IL-10 and/or IFNg
on MHC Class II Steady-State mRNA and
Synthesis of MHC Class II Subunits from
Monocytes
Monocytes were cultured for 15 hr in the pres-
ence of 10 mg/ml anti-IL-10 MAb (2IL-10) or
400 U/ml IL-10. Identical cultures were set up
with the addition of 400 U/ml recombinant
human IFNg.
(A) Total RNA was extracted, electropho-
resed, blotted to Nytran membrane, and hy-
bridized to 32P-labeled cDNA probes.
(B) Human monocytes were preincubated
with 10 mg/ml anti-IL-10 MAb (2IL-10) or 400
U/ml IL-10 for 8 hr, and pulsed for 20 min with
[35S]methionine 1 cysteine.
(C) Identical cultures were set up with the
addition of 400 U/ml recombinant human
IFNg. Cells were detergent extracted and an-
tigens were immunoprecipitated with the in-
dicated antibodies from equal amounts of
trichloroacetate-precipitable radioactivity. Pre-
cipitates were analyzed by SDS±polyacryla-
mide gel electrophoresis. Included in all pre-
cipitation experiments was an anti-MHC
class I antibody (W6/32), which was used to
compensate for loading differences.
(D) The intensities of the HLA-DRa bands
from the DA6.147 and rabbit anti-Ii precipi-
tates of control and IL-10±treated monocyte
lysates were quantitated by phosphorimage
analysis and adjusted for differences in load-
ing. The relative amount of Ii that is coprecipi-
tated inabIi complexes from DA6.147precipi-
tates varies among donors.
In this experiment, antibody was added to metabolically which the majority of newly synthesized MHC class II
must traverse on their way to the plasma membranelabeled and chased cells in order for it to bind newly
synthesized MHC class II arriving at the plasma mem- (BeÂ naroch et al., 1995; Warmerdam et al., 1996). Figure
6 shows that MHC class II staining of control monocytesbrane. Figure 5 shows that from monocytes cultured
with the anti-IL-10 MAb and incubated either in the ab- is predominantly localized at the plasma membrane,
with few apparent vesicles staining in the interior of thesence (Figure 5B) or in the presence (Figure 5D) of IFNg,
immediately following the pulse, no MHC class II could cell. Of note, monocytes cultured in the presence of IL-
10 show a punctate vesicular pattern of MHC class IIbe isolated from the plasma membrane. However, MHC
class II was present after 3 hr of chase, and especially expression localized to the interior of the cell, along with
strongly reduced cell surface expression. Moreover, inin the case of IFNg-treated cells, accumulated on the
cell surface following a longer chase (Figure 5D). In con- the IL-10±treated cells, MHC class II localized to vesicles
that costained with CD63 and HLA-DM. Similar resultstrast, a considerably smaller fraction of MHC class II
was precipitated from the plasma membrane of IL-10± were obtained with cells cultured in the presence of IL-
10 and IFNg (data not shown). Close inspection of CD63treated monocytes at all time points. Thus, although
equal amounts of MHC class II molecules were synthe- staining reveals the appearance of CD631 structures
that do not colocalize with HLA-DR (Figure 6B, arrows),sized in control and IL-10±treated monocytes (Figures
5A and 5C), less MHC class II was detected at theplasma whereas the relative position of all HLA-DR1 vesicles
appears superimposable on those of all HLA-DM1 vesi-membrane in the presence of IL-10, suggesting that IL-
10 affects the accumulation of MHC class II at the cles (Figure 6D), implying that, at least in human mono-
cytes, CD63 is more widely expressed in lysosome-likeplasma membrane.
structures. Finally, the colocalization of HLA-DR with
either of these two endosomal markers was not seen inMHC Class II Molecules Occupy MIIC-Like
Compartments in IL-10±Treated Monocytes control monocytes (Figures 6A and 6C), nor was MHC
class I found to colocalize with CD63 in IL-10±treatedWe proceeded to characterize the subcellular localiza-
tion of MHC class II in IL-10±treated monocytes by con- monocytes (Figure 6E). These observations suggest that
IL-10 causes an accumulation of class II in HLA-DM1focal laser scanning microscopy. To this end, mono-
cytes were cultured for 12 hr with the anti-IL-10 MAb lysosomal structures.
or IL-10, fixed in paraformaldehyde, permeabilized with
saponin, and stained with L243, an anti-MHC class II IL-10 Affects Recycling of MHC
Class II MoleculesMAb, in conjunction with antibodies to the MIIC markers
CD63 and HLA-DM. The presence of HLA-DM in lyso- The pulse chase experiments indicated that IL-10 re-
duces the accumulation of MHC class II on the plasmasome-like structures identifies a compartment through
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Figure 5. Antibody Capture of Accumulated MHC Class II Molecules
on the Plasma Membrane of Monocytes Cultured in the Presence
or Absence of IL-10 and IFNg
Monocytes were preincubated in the presence of (A) 10 mg/ml anti-
IL-10 MAb (2IL-10) or (B) 400 U/ml IL-10. (C and D) Identical cultures
were set up with the addition of 400 U/ml recombinant human IFNg.
Cells were pulsed for 20 min with [35S]methionine 1 cysteine and
chased in the same conditions in which they were preincubated. At
the times indicated, cells were divided into two equal portions. One
portion was detergent extracted immediately (A andC) and immuno-
precipitated with the conformation dependent anti-MHC class II
antibody, L243. The other portion was incubated with anti-MHC
class II MAb prior to detergent extraction (B and D). These cells were
subsequently extracted in the presence of unlabeled monocytes
containing a 5-fold excess of MHC class II, and the immunoprecipi-
tates were analyzed by SDS-PAGE. In the case of the 0 chase time
point, the first of the two lanes represents an additional aliquot of
Figure 4. Formation of SDS-Stable MHC Class II Complexes in
cells that were precipitated with the anti-b chain±specific class II
Monocytes Cultured in the Presence or Absence of IL-10 and IFNg
MAb, Q5/13. This was done to ensure that after the pulse, al-
(A) Monocytes were preincubated for 8 hr with 10 mg/ml anti-IL-10 though no class II could be precipitated from the cell surface, the
MAb (-IL-10) or 400 U/ml IL-10 and pulsed for 20 min with [35S]methi- material could be precipitated from inside the cell using this non±
onine 1 cysteine. (B) Identical cultures were set up with the addition conformation-dependent antibody. Although there appears to be a
of 400 U/ml recombinant human IFNg. Cells were lysed immediately difference in the electrophoretic mobility of the MHC class II sub-
after labeling or were chased for 2 hr under conditions in which they units arriving at the plasma membrane in the presence of IL-10 as
were preincubated and then lysed. Extracts were precipitated with compared to that in the presence of the anti-IL-10 MAb (D), this
DA6.147, an anti-MHC class II MAb; eluted in nonreducing SDS- difference is not reflected in the degree or kinetics of sialylation,
sample buffer, heated either at 228C or 1008C; and analyzed by SDS- which represents the terminal carbohydrate posttranslational modi-
PAGE. The positions of the free MHC class II a, free MHC class II fication (data not shown). Moreover, this apparent difference in gly-
b, and free Ii, and the SDS-stable ab complexes are indicated. Note cosylation does not affect the arrival of MHC class II to the MIIC in
that in nonreducing SDS-PAGE the Ii comigrates with HLA-DRa. the presence of IL-10 (see Figures 4 and 6).
(Figure 7B), although the relative intensity of surfacemembrane. We next studied whether IL-10 had an effect
on the plasma membrane pool of MHC class II. Anti- staining decreased in accordance with the internaliza-
tion of these molecules. In contrast, IL-10 caused anMHC class II-F(ab)9±biotin conjugates (L243 F(ab)9-bio-
tin) were bound to monocytes that had been preincu- accumulation of MHC class II (Figure 7D) but not CD14
(Figure 7F) in internal structures, indicating that this cy-bated in the presence of IL-10 or the anti-IL-10 MAb.
Monocytes were returned to culture, and at 90 min ali- tokine specifically affects the dynamics of the plasma
membrane pool of MHC class II.quots of cells were removed, fixed, permeabilized, and
analyzed by confocal microscopy for the presence of To quantitate the effect of IL-10 on the plasma mem-
brane pool of MHC class II, the kinetics of internalizationMHC class II. Figure 7 shows that MHC class II mole-
cules are expressed at the plasma membrane in mono- was determined by flow cytometry on nonpermeabilized
cells. Monocytes were cultured and stained as de-cytes cultured with the anti-IL-10 MAb and maintained
on ice (Figure 7A). This pattern of expression did not scribed above. Figure 7G shows that in control mono-
cytes, there was a precipitous loss of MHC class II upchange when internalization was allowed to proceed
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Figure 6. Intracellular Immunofluorescence Analysis of MHC Class II Expression from Monocytes Cultured in the Presence or Absence of
IL-10
Monocytes were cultured for 12 hr in the presence of 10 mg/ml anti-IL-10 MAb (A and C) or 400 U/ml IL-10 (B, D, and E). At the end of culture,
cells were washed; fixed; permeabilized with saponin; and stained with L243±fluorescein isothiocyanate, an anti-HLA-DR MAb (A±D), or W6/
32-FITC (anti-MHC class I MAb) (E), together with either an anti-CD63 rabbit serum followed by a Texas Red±conjugated anti-rabbit antibody
(A, B, and E) or an anti-HLA-DM antibody followed by a Texas Red±conjugated anti-mouse IgG (C and D). Cells were analyzed by confocal
laser scanning immunofluorescent microscopy. Arrows in (B), CD631 structures that are negative for HLA-DR.
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Figure 7. Internalization of MHC Class II Mol-
ecules from Monocytes Cultured in the Pres-
ence or Absence of IL-10
Monocytes were preincubated at 378C for 6
hr in the presence of 10 mg/ml neutralizing
antibody to IL-10 (A and B) or 400 U/ml IL-10
(C±F). Cells were washed at 48C and incu-
bated with either L243 F(ab)9 (anti-HLA-DR)
MAb conjugated to biotin (A±D and G) or an
anti-CD14 F(ab)9 biotin conjugate (E, F, and
H). Cells were either kept on ice (A, C, and E)
or returned to culture under the same condi-
tions in which they were preincubated (B, D,
and F). Following a 90 min incubation at 378C,
cells were fixed, permeabilized, incubated
with streptavidin-FITC, and analyzed by con-
focal laser scanning immunofluorescent mi-
croscopy. Alternatively, aliquots of unperme-
abilized cells were removed at the indicated
time points (G and H), stained with avidin-PE,
and analyzed by flow cytometry.
to 15 min following warming of the cells to 378C. This from the surface in IL-10±cultured monocytes. The re-
duced reappearance of internalized class II is specific,drop corresponds to 30%±40% of total binding at time
0 and appears to be consistent with the decrease in since IL-10 did not affect CD14 in a comparable manner
(Figure 7H). This suggests that IL-10 incubation inhibitsintensity of plasma membrane staining observed by im-
age analysis following internalization. After 15 min, the the return of internalized MHC class II molecules to the
plasma membrane, consistent with microscopic analy-level of MHC class II remained relatively constant
through 4 hr in culture. The shape of this binding curve sis of class II±bearing internal structures present in IL-
10±treated but not control monocytes. Therefore, IL-10is consistent with internalization of MHC class II fol-
lowed by the attainment of an equilibrium of internalized appears to affect both the exocytosis and recycling of
MHC class II in human monocytes.and reexpressed molecules.
The plasma membrane dynamics of MHC class II in
monocytes treated with IL-10are notably different. Here,
internalization proceeds for a longer period, although Discussion
the rate of this process, as defined by the slope of the
curve prior to its inflection, is not appreciably different The ability of IL-10 to inhibit antigen-specific T cell clone
proliferation when monocytes are used as antigen-pre-from that in controls. Moreover, an equilibrium between
internalized and returning molecules is not as evident as senting cells has been documented (de Waal Malefyt et
al., 1991b). IL-10 down-regulates cell surface expressionthe L243 F(ab)9-biotin complexes continue to decrease
Immunity
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of three important monocyte-encoded glycoproteins im- types insignaling events downstream of the IL-10 recep-
tor. Such differences in IL-10 signaling have been docu-plicated in T cell stimulation (e.g., CD80, CD86, and
mented; in one example, they lead to differential assem-CD58 [Kubin et al., 1994; Willems et al., 1994]), as well
bly of Stat1a and Stat3 complexes in human T cells andas MHC class II (de Waal Malefyt et al., 1991a, 1991b).
monocytes (Finbloom and Winestock, 1995).Antibody blocking experiments show that of these cell
Our results support a model whereby IL-10 reducessurface molecules, anti-MHC class II antibodies block
the arrival of newly synthesized MHC class II at theproliferation of T cell clones to the greatest extent
plasma membrane. This idea is based on our observa-(R. d. W. M., unpublished data). This illustrates the im-
tions that newly synthesized MHC class II is impededportance of IL-10±mediated down-regulation of MHC
from accumulating at the plasma membrane in mono-class II on the function of human monocytes.
cytes cultured in the presence of IL-10. Although theseThe effects of IL-10 on gene regulation in monocytes
observations are not sufficient to confirm our conclu-have been described primarily for the transcription rate
sion, the accumulation of MHC class II in HLA-DM±and mRNA stability of IL-1a, IL-1b, IL-6, IL-12, TNFa,
containing compartments in IL-10±cultured but not con-IFNa, IL-8, MIP1a, GM-CSF, M-CSF, G-CSF, and CD80
trol-cultured cells, as seen by immunofluorescence and(de Waal Malefyt et al., 1991a, 1993; Chin and Kostura,
immunoelectron microscopy (data not shown), support1993; Gruber et al., 1994). We have shown that IL-10
this interpretation. Since HLA-DM identifies a compart-does not affect the steady-state message levels of MHC
ment through with the majority of newly synthesizedclass II, Ii, or HLA-DM. Instead, our results reveal a
class II must traverse prior to their arrival at the plasmapreviously undescribed mechanism of MHC class II
membrane (BeÂ naroch et al., 1995; Warmerdam et al.,down-regulation mediated by IL-10 on human mono-
1996), these observations indicate that IL-10 affects thecytes. This occurs through a posttranslational effect on
biosynthetic pool of MHC class II.the exocytosis of newly synthesized MHC class II mole-
Earlier studies by Reid and Watts (Reid and Watts,cules to the plasma membrane, along with a negative
1990) and more recent work by Pinet and Cella (Pineteffect on the recycling of the plasma membrane pool of
et al., 1995; Cella, 1997) have shown that internalizedthese molecules. Of particular note is our observation
MHC class II can be recycled. Our results also indicatethat IL-10 acts at a relatively late stage in MHC class II
that IL-10 affects the reexpression of internalized MHCbiosynthesis, following the loading of antigenic peptides
class II. In fact, while 50% of the original amount of L243in an endosomal compartment. This feature distin-
F(ab)9-biotin remains on the surface in control mono-guishes the effects of IL-10 from those of monensin
cytes following 12 hr incubation, those cultured in the(Machamer and Cresswell, 1984), chloroquine (Nowell
presence of IL-10 have only 10% (data not shown). Thisand Quaranta, 1985), concanamycin B (BeÂ naroch et al.,
suggests that the effect of IL-10 on the recycling pool1995), and leupeptin (Neefjes and Ploegh, 1992), all of
of MHC class II also contributes to the overall down-which affect MHC class II exocytosis prior to the genera-
regulation of these molecules, as depicted in Figure 2.tion of peptide-loaded complexes.
The image analysis revealing internalized MHC class IIThe rapid down-regulation of MHC class II by IL-10
trapped inside IL-10± but not control-cultured mono-is selective because IL-10 treatment of monocytes re-
cytes supports this interpretation. IL-10 may thereforesults in the up-regulation of cell surface CD16, CD64,
be affecting factor(s) specific for trafficking from theand TNFa receptors (te Velde et al., 1992). Moreover,
MIIC or a factor that acts on both the MIIC and a recy-virtually no effects can be seen on the expression of
cling compartment.surface MHC class I or CD14 (de Waal Malefyt et al.,
The effect of IL-10 on a single labeled cohort of MHC1993) following a 15 hr incubation of monocytes in the
class II is not absolute, whether we are measuring thepresence of IL-10. Extended incubations up to 24 hr
accumulation at the plasma membrane or recycling.
reveal only marginal effects on surface MHC class I
However, this impedance is cumulative, such that what-
levels (data not shown), possibly because of an effect
ever small proportion of molecules that arrive on the
on the expression of TAP (transporter associated with
plasma membrane in the presence of IL-10 are now
antigen processing) (Salazar-Onfray et al., 1997, Zeidler subject to the effects of IL-10 upon their internalization.
et al., 1997). Meanwhile, the proportion of MHC class II that success-
The effect of IL-10 on MHC class II expression is fully recycle back to thesurface are subject to theeffects
cell-type specific. We have examined MHC class II on of IL-10 upon a subsequent round of internalization.
activated T cells and resting B cells isolated from periph- We have described a mechanism by which IL-10
eral blood, as well as on B-lymphoblastoid cell lines, down-regulates the cell surface expression of MHC
all of which express IL-10 receptors (Liu et al., 1994). class II molecules by affecting the appearance of ma-
IL-10 did not down-regulate surface expression of MHC ture MHC class II ab peptide complexes on the surface
class II molecules on these cells. However, IL-10± of freshly isolated human monocytes. Our results, to-
mediated inhibition of MHC class II expression on Lang- gether with the recent observations on MHC class II
erhans cells (PeÂguet-Navarro et al., 1994) and macro- exocytosis and recycling by monocyte-derived dendritic
phage-derived microglial cells (Frei et al., 1994) have cells (Cella, 1997) demonstrate that MHC class II traffick-
been reported. Therefore, the effect of IL-10 on MHC ing by professional antigen-presenting cells is a highly
class II biosynthesis appears to be a myeloid-restricted regulated and dynamic process that can be controlled
phenomenon, the specificity of which may be attribut- by pro- and anti-inflammatory cytokines. Furthermore,
this down-regulation of MHC class II exocytosis andable to differences between myeloid and lymphoid cell
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medium containing 1% human serum and 2 mM each of unlabeledrecycling contributes to the anti-inflammatory and im-
methionine and cysteine with the addition of either the anti-IL-10munosuppressive activities of IL-10.
MAb or IL-10. At various time points, cells were removed from 378C
and diluted in cold PBS.
Experimental Procedures
Detergent Extraction and Immunoprecipitation
Cells and Antibodies Immunoprecipitation from detergent extracts was performed as pre-
Monocytes were purified by negative selection from peripheral viously described (Koppelman and Cresswell, 1990). For samples
blood mononuclear cells of healthy donors. In brief, 3 3 108 ficol that received antibody prior to detergent extraction, cells were
separated mononuclear cells were incubated on ice with a cocktail washed three times with PBS and incubated with the anti-HLA-DR
of MAbs (Becton-Dickinson, Mountain View, CA) consisting of aCD2 MAb L243 at 10 mg/ml for 1 hr on ice. Antibody-coated cells were
(Leu-5A), aCD3 (Leu-4), aCD8 (Leu 2a), aCD19 (Leu-12), aCD20 (Leu- washed three times in PBS and extracted in PBS containing 1%
16), aCD56 (Leu-19), aCD67 (IOM 67) (Immunotech, Westbrook, ME), Nonidet P-40, 1 mg/ml bovine serum albumin, and unlabeled cells
and anti-glycophorin antibody (10F7MN, American Type Culture providing 5- to 10-fold excess of MHC class II molecules. Nuclei
Collection, Rockville, MD). Antibody-bound cells were washed and and cell debris were cleared by centrifugation, and the supernatant
then incubated with sheep anti-mouse IgG coupled magnetic beads was incubated with Protein G-Sepharose beads for 30 min at 48C.
(Dynal, Oslo, Norway) at a bead-to-cell ratio of 20:1. Antibody-bound
cells were separated from monocytes by application of a magnetic mRNA Isolation and Northern Analyses
field. The anti-IL-10 MAb 12G8 was produced at DNAX (Abrams, Total RNA was isolated from 107 monocytes using RNA STAT-60
1992). Soluble IL-10R (Liu et al., 1994) was a kind gift from K. Moore (Tel-Test, Friendswood, TX). RNA was electrophoresed, transferred
(DNAX). W6/32 (Barnstable et al., 1978) (American Type Culture to membrane, and hybridized with probes labeled to high specific
Collection) and G46-2.6 (IgG1, Pharmingen, San Diego, CA) antibod- activity (.108 cpm/mg) by the hexamer labeling technique (Feinberg
ies react with a conformational epitope on human MHC class I and Vogelstein, 1983). Filters were hybridized, washed under strin-
molecules. DA6.147 (Guy et al., 1982), an anti-DRa MAb; Map.DM1, gent conditions, and developed as previously described (de Waal
an anti-HLA-DM MAb; and rabbit anti-Ii were kindly provided by Malefyt et al., 1989).
Peter Cresswell (Yale Medical School, New Haven, CT) and Frances
Brodsky (University of California, San Francisco, CA). TuÈ 36 (Shaw Preparation of F(ab)92, F(ab)9 and Biotinylated F(ab)9et al., 1985) and L243 (Lampson and Levy, 1980) detect a conforma- F(ab)92 fragments of the anti-IL-10 MAb 12G8 were prepared usingtional determinant on HLA DR ab and abIi complexes. Q5/13 (Qua- an Immunopure F(ab)92 Preparation Kit (Pierce, Rockford, IL). F(ab)9ranta et al., 1981) reacts with an epitope on HLA-DRb chains. fragments of the anti-HLADR MAb L243 were prepared using an
Immunopure F(ab)9 Preparation Kit (Pierce). F(ab)9 fragments were
Cell Culture Conditions biotinylated by dialyzing protein into 50 mM sodium bicarbonate
Monocytes were seeded at 3 3 106/ml in Yssel's medium (Gemini (pH 8.5) and adding a 10-fold molar excess of NHS-SS-biotin (sulfo-
Bioproducts, Calabasas, CA) containing 1% human AB serum. For succinimidyl 6-(biotinamido) hexanoate) (Pierce). The reaction pro-
metabolic labeling studies, preincubations with IL-10 were done for ceeded for 2 hr at 48C. Unreacted biotin was removed by centrifuga-
8±10 hr using 400 U/ml IL-10. The neutralizing antibody to IL-10 tion through a Centricon 30 (Amicon, Beverly, MA). The sample was
(12G8) was used at 10 mg/ml. The F(ab)92 fragment of 12G8 was diluted in 10 mM sodium phosphate, 150 mM sodium chloride and
used at 30 mg/ml. Soluble IL-10 receptor was added to cultures at recentrifuged two successive times to remove unreacted biotin.
a final concentration of 50 mg/ml. Recombinant human IFNg (R&D
Systems, Minneapolis, MN) was added to cultures at a final concen- Acknowledgments
tration of 400 U/ml.
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